Cui Chen Selected Research

Guanine Nucleotides

9/2022	Overexpression of GNA13 correlates with poor prognosis in esophageal squamous cell carcinoma after esophagectomy.
11/2016	High expression of GNA13 is associated with poor prognosis in hepatocellular carcinoma.
1/2016	GNA13 as a prognostic factor and mediator of gastric cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cui Chen Research Topics

Disease

24	Neoplasms (Cancer) 05/2022 - 11/2014
9	Nasopharyngeal Carcinoma 09/2017 - 11/2012
4	Esophageal Squamous Cell Carcinoma 09/2022 - 08/2013
4	Neoplasm Metastasis (Metastasis) 05/2022 - 11/2014
4	Lymphoma (Lymphomas) 01/2022 - 01/2019
4	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2013
4	Colorectal Neoplasms (Colorectal Cancer) 08/2016 - 10/2014
2	Hepatocellular Carcinoma (Hepatoma) 05/2022 - 01/2017
2	Hypertension (High Blood Pressure) 09/2021 - 10/2014
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2019
2	Breast Neoplasms (Breast Cancer) 05/2018 - 01/2016
2	Carcinogenesis 01/2018 - 01/2016
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017 - 06/2016
2	Neutropenia 11/2014 - 02/2013
2	Diarrhea 11/2014 - 02/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	COVID-19 01/2021
1	Thrombotic Thrombocytopenic Purpura 04/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Hodgkin Disease (Hodgkin's Disease) 01/2019
1	Hypertrophy 01/2019
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Skin Neoplasms (Skin Cancer) 02/2018
1	Melanoma (Melanoma, Malignant) 02/2018
1	Pathologic Processes 01/2018
1	Birth Weight (Birth Weights) 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cardiomegaly (Heart Hypertrophy) 01/2018
1	Weight Gain 01/2018
1	Diabetic Cardiomyopathies 01/2018
1	Body Weight (Weight, Body) 10/2017
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Signet Ring Cell Carcinoma 08/2016

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2019 - 03/2014
5	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 08/2013
5	Biological ProductsIBA 01/2019 - 04/2014
5	Immunoconjugates (Immunoconjugate)IBA 05/2018 - 10/2015
4	MicroRNAs (MicroRNA)IBA 05/2022 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 12/2021 - 01/2013
4	AntigensIBA 05/2018 - 10/2015
3	Guanine NucleotidesIBA 09/2022 - 01/2016
3	Carrier Proteins (Binding Protein)IBA 09/2022 - 01/2016
3	AntibodiesIBA 01/2016 - 10/2015
2	Gemcitabine FDA Link 01/2022 - 11/2012
2	LigandsIBA 12/2021 - 01/2012
2	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2016
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2020 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2019 - 02/2018
2	Oxidoreductases (Dehydrogenase)IBA 01/2018 - 01/2017
2	Inosine Monophosphate (IMP)IBA 01/2018 - 01/2017
2	Indicators and Reagents (Reagents)IBA 01/2017 - 08/2013
2	AlbuminsIBA 01/2017 - 01/2017
2	Cytotoxins (Cytolysins)IBA 01/2017 - 11/2016
2	Messenger RNA (mRNA)IBA 11/2014 - 07/2014
2	Fluorouracil (Carac)FDA LinkGeneric 11/2014 - 02/2013
2	PlatinumIBA 02/2013 - 11/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2022
1	anlotinibIBA 01/2022
1	pegaspargase (Oncaspar)FDA Link 01/2022
1	Asparaginase (Elspar)FDA Link 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2021
1	thiamine triphosphorate (TTP)IBA 04/2020
1	Sincalide FDA Link 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2019
1	Rituximab (Mabthera)FDA Link 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	pyrrolo(2,1-c)(1,4)benzodiazepineIBA 01/2019
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2018
1	Death Domain ReceptorsIBA 02/2018
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	fibroblast growth factor 21IBA 01/2018
1	LipidsIBA 01/2018
1	Atrial Natriuretic Factor (ANF)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Collagen Type I (Type I Collagen)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Long Noncoding RNAIBA 01/2018
1	Pharmaceutical PreparationsIBA 10/2017
1	Protein Tyrosine PhosphatasesIBA 09/2017
1	Phosphate Transport Proteins (Phosphate Transporter)IBA 01/2017
1	MEDI0641IBA 01/2017
1	CateninsIBA 01/2017
1	SodiumIBA 01/2017
1	Alkaline PhosphataseIBA 01/2017
1	Viral DNAIBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 07/2016

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2017 - 11/2012
5	Therapeutics 02/2018 - 11/2014
1	Esophagectomy 09/2022
1	Radiotherapy 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2021
1	Immunomodulation 01/2017